| HOME >> MEDICINE >> TECHNOLOGY |
unproven approaches to protect against infectious diseases, including
harnessing natural or synthetic immune responses, or eliminating the
need for an effective immune response.
-- Creating drugs or delivery systems that limit the emergence of
resistance: Innovative ideas for discovering or delivering drugs that
are less likely to lose effectiveness because of resistance developing
in the disease-causing agent.
-- Creating new ways to prevent or cure HIV infection: Innovative ideas
for HIV prevention or treatment methods that fall outside current
research on vaccines, antiretroviral drugs, and other biomedical and
behavior-change strategies.
-- Exploring the basis for latency in TB: Unconventional approaches to
understanding latent TB infection, with the goal of discovering new
ways to identify and eliminate latent infection, and break the cycle of
TB transmission.
Grant proposals for the first Explorations funding round will be accepted online at http://www.gcgh.org/explorations from March 31 through May 30, 2008; applicants must register intent to submit a proposal by May 15, 2008.
Once the first Explorations funding round is complete, the foundation will announce subsequent funding rounds. Topics may vary over time, to cover a range of priorities in global health research.
Full descriptions of the initial topic areas and application instructions are available at http://www.gcgh.org/explorations.
Guided by the belief that every life has equal value, the Bill &
Melinda Gates Foundation works to help all people lead healthy, productive
lives. In developing countries, it focuses on improving people's health and
giving them the chance to lift themselves out of hunger and extreme
poverty. In the
'/>"/>
| SOURCE Bill & Melinda Gates Foundation Copyright©2008 PR Newswire. All rights reserved |